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Abstract Silver-enhanced labeling method has been
employed in immunochromatographic assays for improv-
ing the sensitivity of detecting pathogens. In this paper, we
apply the silver enhancement technique for biomolecular
signal ampliﬁcation in a gold nanoparticle-based conduc-
timetric biochip. We show that the response of the silver-
enhanced biochip comprises two distinct regions namely:
(a) a sub-threshold region where conduction occurs due to
electron hopping between silver islands and the electrolyte
and (b) an above-threshold region where the conduction is
due to a direct ﬂow of electrons. These two regions are
characterized by different conduction slopes, and we show
that combining the information from both these regions can
improve the sensitivity of the biochip. Results from fabri-
cated prototypes show a dynamic range of more than 40 dB
and with a detection limit less than 240 pg/mL. The
fabrication of the biochip is compatible with standard
complementary metal–oxide–semiconductor (CMOS) pro-
cesses making it ideal for integration in next-generation
CMOS biosensors.
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Introduction
Biosensors have emerged as important analytical tools for
detecting and controlling disease outbreaks, which
according to the United States Department of Agriculture
(USDA) cause $2.9–6.7 billion worth of losses every year
[1]. Biosensors typically consist of a biological recognition
layer (e.g. enzymes, antibodies, DNA etc.) integrated in
proximity to a transducer which converts the binding event
between the target and its speciﬁc probes into a measurable
signal. For instance, in the most widely used enzyme-
linked immunosorbent assay (ELISA) technique, the
hybridization event between antibodies and antigen is
reported using a colorimetric signal and with detection
limits approaching picomolar range. Out of all detection
methods used in biosensors, optical-based technique is the
most popular one because of its high-sensitivity and its
ability to remotely interrogate the information on the bio-
sensor using light or laser. However, biosensors with
electrical readouts offer several advantages over their
optical counterparts due to their reduced cost, reduced form
factor, and the ease of signal acquisition [2, 3]. One of the
major challenges in the electrical or impedance based
detection is low signal-to-noise ratio when compared to
optical detection, which is attributed to the large magnitude
of the background signal [3]. In this regard, a biomolecular
ampliﬁcation technique called ‘‘silver enhancement’’ could
be ideal to boost the signal-to-noise ratio (SNR) of con-
ductimetric biosensors to be comparable to that of its
optical counterparts. In fact, silver enhancement has been
previously proposed and used for improving the detection
range in optical biosensors. In [4–7], silver enhancement
has been used in conjunction with labeling with gold
nanoparticles for optical detection in immunoassays. In [5],
it was reported that the conjugation signiﬁcantly increased
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DOI 10.1007/s11671-010-9542-0the detection limit of ricin to 100 pg/mL. We show in this
paper that for conductimetric biosensors, silver enhance-
ment signiﬁcantly improves the SNR and in the process can
achieve detection sensitivity comparable or better than an
optical based system. Also, performing signal enhancement
at the biomolecular level before performing electrical read-
out would reduce the effects of background interference
[8–10].
The model conductimetric biochip used for this study
has been constructed using functionalized gold nanoparti-
cles on the high-density interdigitated microelectrode
array. The interdigitated electrodes provide a large active
area to facilitate binding between the analyte and the
detection probe and hence have several advantages over
non-interdigitated electrode arrays [11, 12]. The salient
features of this study include: (a) a simple and robust
electrical detection method using a combination of gold
nanoparticle labels with silver ampliﬁcation technique; (b)
characterization of the extent to which the nanoparticle
adsorption can be quantiﬁed using silver enhancement; (c)
characterization of two distinct biomolecular transistor
responses that are the sub-threshold and the above-thresh-
old regions of the operation, and (d) characterization of the
biochip sensitivity and the detection limit using repeated
and controlled experiments. This paper is organized as
follows: Sect. 2 describes the operating principle of the
silver enhancement technique when applied to gold nano-
particles and the high-density microelectrode biochip.
Section 3 describes the fabrication method of biochips and
surface functionalization of biochips. Section 4 presents
experimental results of detecting biomolecules using rabbit
and mouse IgG as model antigen, which verify the prin-
ciple of silver enhancement and the functionality of the
biochip. Section 5 concludes with a brief discussion and
the future work.
Biochip Architecture and Principle of Operation
The principle of conductimetric biochip detection is shown
in Fig. 1 where initially probes speciﬁc to the target mol-
ecules are immobilized in the regions between two elec-
trodes. When the analyte is applied, the target biomolecules
interact with the speciﬁc probes. The secondary antibodies
conjugated with gold (Au) nanoparticle are then applied to
the biochip, which leads to the formation of a sandwich
array as shown in Fig. 1a. This conﬁguration is denoted as
the ‘‘cutoff’’ region, since the current measured between
the electrodes (for a ﬁxed potential difference) is small.
In the next step of the silver enhancement procedure, the
active component (with gold nanoparticles) of the biochip
is exposed to a solution of Ag (I) and hydroquinone
(photographic developing solution). The gold nanoparticles
act as a catalyst and reduce silver ions into metallic silver
in the presence of a reducing agent (hydroquinone). The
reduced silver then deposits on the gold surface, thus
enlarging the size of the gold nanoparticles. As the size of
the silver islands grows, they provide shorter paths for
electrons to hop between the electrodes. The region of
operation when the distance between the electrodes has not
been fully bridged by the silver islands is the sub-threshold
region (see Fig. 1b).With the increase in enhancement
time, the consistent growth of silver-enhanced particles
completely bridges the area between the electrodes. Under
this condition, the device enters the above-threshold
region of operation where a ﬂow of current can be mea-
sured when a ﬁxed potential is applied between the elec-
trodes (Fig. 1c). The time required for the device to reach
the threshold from the cutoff region is known as the
transition time. In this paper, we use the sub-threshold and
above-threshold characteristics of the device for conduc-
timetric measurement of the concentration of the target
biomolecules.
Biochip Fabrication and Surface Functionalization
The biochips were fabricated from 400 silicon wafers
(p-type 100, thickness 500–550 lm). A 2-lm thick layer of
thermal oxide was grown over the silicon to serve as an
insulator between the electrodes and the substrate. Photo-
lithography was used to pattern photoresist, metal elec-
trodes were deposited by the evaporation of 10 nm of
chrome under 100 nm of gold, and a lift-off process was
used to develop the interdigitated electrode array. Figure 2
shows the high-density interdigitated electrodes biochip
(a) (b) (c)
Fig. 1 The operating principle
of the silver-enhanced
biomolecular transistor with
three distinct regions of the
operation
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123fabricated using a standard MEMS technology described
above. Each electrode ﬁnger has a length of 5,000 lm, a
width of 5 lm, and an inter-electrode spacing of 6 lm. The
surface of biochips was then modiﬁed for immobilizing the
antibody. The chips were ﬁrst immersed in acetone in a
crystallizing dish for 10 min to dissolve away the protec-
tive PR layer. The chips were then treated with 1:1 mixture
of concentrated methanol and hydrochloric acid for 30 min
followed by immersion into boiling distilled water for
30 min. The biochips were allowed to air dry completely.
The cleaning and drying of the biochips are now ready for
silanization where it occurred in an anaerobic glove box.
The biochips were immersed in a crystallizing dish con-
taining a solution of 2% 3-mercaptopropyltrimethylox-
ysilane (MTS) (Sigma; St. Louis, MS) for 2 h. The chips
were then rinsed in toluene and allowed to dry completely.
After silanization, N-y-maleimidobutyryloxy succinimide
ester (GMBS) (Sigma; St. Louis, MA) was chosen as
crosslinkers to avoid multi-protein complex [13]. The
crosslinking reagent was dissolved in a minimum amount
of dimethylformamide (DMF) and then diluted with etha-
nol to a ﬁnal concentration of 2 mM. The silanized sub-
strate was treated with crosslinker for 1 h and washed in
phosphate buffered saline (PBS, pH 7.4). After the appli-
cation of the crosslinker, antibody (Sigma; St. Louis, MA)
was immobilized onto the biochip active surface. Figure 3
summarizes the process of biochip surface functionaliza-
tion. The biochips were placed in a petri dish, sealed with
paraﬁlm, and allowed to incubate at 37C for 1 h. The
biochips were then treated with 2 mg/mL bovine serum
albumin (BSA) (Sigma; St. Louis, MA) as blocking reagent
for 45 min. After incubation, the biochip surface was
rinsed with PBS (pH 7.4) and allowed to air dry. The
confocal laser scanning microscopy image was used to
validate antibody immobilization and determine where it
occurred (Fig. 4). The image shows that the antibody
immobilization was only occurring on the silicon dioxide
area between the electrodes, thus proving the effectiveness
of the surface functionalization.
Results and Discussions
Veriﬁcation of the Operating Principle
The ﬁrst step in verifying the silver enhancement principle
is to measure the size of the silver-enhanced gold nano-
particles in the silver enhancer solution (Ted Pella, Inc.,
CA) with respect to the silver enhancing time. For this
experiment, Zetasizer Nano (Malvern Instruments Ltd,
UK) was used to characterize the particle size. Figure 5
shows the linear relationship between the silver enhancing
time and the size of gold particles. We have observed that
the 40-nm gold nanoparticles will reach average size of
Fig. 2 The high-density interdigitated microelectrode biosensor
Fig. 3 The process of biochip
surface functionalization
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1231.2 lm when exposed to the silver enhancer for approxi-
mately 10 min. This interesting property makes the silver
enhancement principle suitable for signal ampliﬁcation in
conductimetric biosensors.
To evaluate the detection capabilities of the biochip, we
dispense 2.5 mM/mL gold anti-IgG conjugate onto the
biochip surface for 1 h and then treat the biochip with silver
enhancer solution (Ted Pella, Inc., CA). To stop silver
enhancement, the biochip was rinsed with distilled water
and was dried with N2. Figure 6 shows the microscopic
observations before and after 35 min silver enhancing time.
As gold nanoparticles are 40 nm size and they can not be
observed by in Fig 6a, where as they can be clearly
observed after silver enhancement (see Fig. 6b). It can also
be seen that the silver-enhanced gold particles form a bridge
between the interdigitated electrodes. Figure 7 shows the
SEM image of the bridge formed by silver-enhanced gold
particles and then veriﬁes the operating principle.
IgG Detection
Based on the principle of silver enhancement, we conduct
IgG detection by ﬁrst applying rabbit IgG onto the active
Fig. 4 Confocal laser scanning microscopy image of electrodes show-
ing FITC-labeled bovine IgG only immobilized on silicon dioxide
surfaces (black areas are the electrodes where no IgG are present)
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Fig. 5 The relationship between the silver-enhanced gold particle
size and the silver enhancing time
Fig. 6 Microphotographs for
the biochip active surface.
a before silver enhancement
b 35 min after silver
enhancement
Fig. 7 SEM image of the bridge formed by enlarged gold particles
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123area of the anti-rabbit IgG biochip allowing incubation for
30 min. Goat anti-rabbit IgG and gold conjugates were
then applied and were incubated for 30 min. Excess gold
conjugates were washed with PBS solution. Electrical
measurements are taken after each treatment of the biochip
with the silver enhancer solution, and the conductance
between the electrodes was measured using a BK mul-
timeter Model AK-2880A (Worchester, MA).
Figure 8 shows the conductance between the electrodes
increases with the increasing exposure to the silver
enhancer solution where the insert ﬁgure shows the con-
ductance measurement in the logarithmic domain. The
conductance increases when the biochip is exposed more
in the silver enhancer solution as expected. It also clear
shows the response has three distinct operation region (A,
B, and C), which veriﬁes the operating principle of the
silver-enhanced gold nanoparticle-based biochip. During
the sub-threshold region (labeled as B) of the operation,
gold nanoparticles grow in the presence of silver enhancer
solution thus leading to a shorter path for electron trans-
port. But during this stage, enhanced gold particles have
not formed the bridge to short the electrodes. With the
increase in enhancement time, the consistent growth of
silver-enhanced particles completely bridges the area
between the electrodes, and there is immediate transition
from state B to C when it happened (shown a step from B
to C in the inserted ﬁgure in Fig. 8). In the stage C, more
bridges formed by gold nanoparticles are building up in
parallel, thus leading to more conductance increase until it
become to a more stable state. Bovine IgG biochips were
used as negative control experiments, and we have
observed that the conductance of ‘‘control’’ biochip start
to increase at 10 min. It means that the non-speciﬁc
binding actually occurred, but the number of such events
is much smaller than the number of speciﬁc binding
events. Thus, the biochip is able to detect target IgG in
t h ep r e s e n c eo fb a c k g r o u n dn o i s e .W eh a v es e e nt h a tt h e
measurement results are stable several days after the
experiments have been conducted. Also, the results in
Fig. 8 show that the detection range that can be achieved
by proposed biosensor is 40 dB with respect to the control
conductance.
We also conducted rabbit IgG detection using different
IgG concentrations, and Fig. 9 shows the conductance
measurements at 45 min with three IgG concentrations and
the control experiment. For each concentration, the
experiment is repeated three times, and the standard devi-
ation is also shown in the graph. It clearly shows that
pathogenic and non-pathogenic cases can be easily distin-
guished even with low concentration of IgG. As seen in
the graph, the conductance of biochip decrease with
the decrease of the IgG concentration level, implying a
decreasing of the signal-to-noise ratio. Similar experiments
have been performed using anti-mouse IgG biochip with
the mouse IgG detection, and the results are shown in the
Fig. 10. These repeated and controlled experimental results
verify the functionality of proposed biochip to detect
biomolecules.
Some researchers have argued that the conductivity-
based silver-enhanced detection is not applicable to quan-
titative concentration assays, because the electrodes are
short circuited above a certain density of the silver-
enhanced gold particles [4]. In the next experiment, we will
show that the quantitative analysis can be achieved by
adjusting silver enhancing time. Figure 11 shows the
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Fig. 8 Conductance of the biochips measured as a function of silver
enhancing time. (Inset) Conductance measurement in logarithmic
domain, which can clearly show that the biomolecular transistor
exhibits three different types of responses (labeled as A, B, and C)
based on the nature of the conductive path across the electrodes. A
cutoff region; B sub-threshold region when the formation of the
conductive bridge between the electrodes is incomplete; C above-
threshold region where the bridge is completely formed by silver-
enhanced gold nanoparticles leading to a step increase in conductance
and conductance slope
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123relation of the silver enhancing time required to reach a
conductance range of 3.8–5 mS as a function of rabbit IgG
concentration. It is interesting to note that 240 pg/mL
rabbit IgG can be detected when the conductance increases
to 3.8 mS at the silver enhancing time of 42 min.
We have shown the experiments to verify the principle
of silver-enhanced electrical detection of biomolecules
using rabbit IgG as model antigen. One issue that other
researchers have not addressed in the silver enhancement
method is the accuracy and possible false positive errors.
Due to the sensitivity of the presence of gold nanoparticles
when exposing to silver, it might have a high level of false
positive results. The typical method of prevention is to
extensively wash the biochips to alleviate non-speciﬁc
binding.However,themethodistimeconsuming,anditisnot
always effective. Another alterative solution is to embed the
biochip with error-correction function by employing encode-
decoding scheme similar to the approach that we have pre-
viously reported [14].
Conclusions
In this paper, we have designed and characterized a silver
enhancement technique for amplifying the signal for gold
nanoparticle label at biomolecular level. The gold nano-
particles serve as nucleation sites about which a reduction
reaction deposits silver and hence enlarges the size of the
gold nanoparticle. Using silver enhancer solution, the gold
antiparticles can grow into a micro size particle and ulti-
mately can bridge the gap between electrodes, leading
a measurable change in conductance. Comprehensive
experiments have veriﬁed the effectiveness of surface
functionalization and the functionality of biochip. The
proposed biochip in conjunction with silver enhancement
provides a simple, effective, and sensitive way of detecting
trace quantity of biomolecules.
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